Panagora Asset Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Panagora Asset Management’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-301	Closed	-$41K	–	2668
2019 Q2	$41K	Sell	301 -3	-1%	-$474	﹤0.01%	2126
2019 Q1	$83K	Buy	304 +150	+97%	+$32.5K	﹤0.01%	1935
2018 Q4	$19K	Buy	154 +27	+21%	+$7.33K	﹤0.01%	2229
2018 Q3	$52K	Buy	127 +107	+535%	+$49.5K	﹤0.01%	2016
2018 Q2	$11K	Buy	+20	New	+$10.6K	﹤0.01%	2259

Other funds holding TCON

PCM

Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

Panagora Asset Management's TCON Position: Q3 2019 in Review

Panagora Asset Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q3 2019, closing a stake of 301 shares — an estimated $41K sold.

Panagora Asset Management first reported a position in TCON in Q2 2018 and held it in 5 quarters. The position peaked at $83K in Q1 2019. 23 funds tracked by Wall St. Rank hold TCON as of Q3 2019.

Panagora Asset Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Panagora Asset Management sold 301 TRACON Pharmaceuticals, Inc. Common Stock shares in Q3 2019, an estimated $41K.
Panagora Asset Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 5 quarters.
Panagora Asset Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $83K in Q1 2019.
23 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.